Dr. Parthasarathy Chandrakesan has a broad background in Stem cell biology, Cancer marker characterization and therapeutics, Gastroenterology and Endocrinology with extensive training and experience in molecular and cellular biology and animal models relevant to the background knowledge. As a fellow (research) at the University of Oklahoma Health Sciences Center, he carried out research investigating the role of NF-kB/b-catenin/Notch signaling during intestinal crypt hyperplasia and neoplasia. He extended his research to explore the novelty hiding behind the core of bacterial infection induced EMT and tumorigenesis in the colon. His major research focus is on Regenerative medicine utilizing the stem cells for clonal expansion culture and experimental therapeutics using novel nanotechnology and ADC combination therapies for cancer treatment. He is honorable member of the American Gastroenterological Association and member of the Society of Reproductive Biology and Comparative Endocrinology.
Molecular Characterization of Stem Cells for Regenerative Therapies; Targeted therapies using novel nanotechnology and ADC combination machinery for Pancreatic, Breast and Colon cancers; Signaling machinery and miRNA deviations as new targets.